Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENDOR plus standard treatment versus placebo plus standard treatment in hospitalized adults with COVID-19
IRCT20100601004076N26Phase 3Completed
- Sponsor
- Ghadiminezhad Daru
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of ENDOR in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Ghadiminezhad Daru. Primary endpoints: Clinical presentation, Radiological findings and 1 more. Started Nov 2021; status: completed.
02
Drugs
ENDOR
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20100601004076N26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100601004076N26.